欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0425/003
药品名称Simva TAD 20 mg
活性成分
    • simvastatin 20.0 mg
剂型Film-coated tablet
上市许可持有人TAD Pharma GmbH Heinz-Lohmann-Str. 5 D-27472 Cuxhaven
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Cyprus (CY)
      simva tad 20mg 24m0183
    • Belgium (BE)
    • Ireland (IE)
    • Latvia (LV)
      Simva TAD 20 mg film-coated tablets
    • Lithuania (LT)
      Simva TAD 20 mg plėvele dengtos tabletės
    • Hungary (HU)
      Simva TAD 20 mg tabletta
许可日期2003/10/13
最近更新日期2019/07/01
药物ATC编码
    • C CARDIOVASCULAR SYSTEM
    • C10 LIPID MODIFYING AGENTS
    • C10A LIPID MODIFYING AGENTS, PLAIN
    • C10AA HMG CoA reductase inhibitors
    • C10AA01 simvastatin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Article 4.8(a)(iii), first paragraph
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase